Sunday, 23 August 2026

Streptococcus

 

1. Introduction & General Properties

  • Taxonomy: Belongs to the family Streptococcaceae, distinguished from Micrococcaceae (Staphylococci) by being catalase-negative.
  • Morphology: Gram-positive, spherical or ovoid cocci arranged in chains or pairs. Chain formation occurs because cell division takes place strictly in a single plane, and daughter cells fail to separate completely.
  • General Features: Non-motile, non-sporing, and often encapsulated.
  • Growth Requirements: They are fastidious facultative anaerobes that require media enriched with blood, serum, or ascitic fluid for growth.

2. Comprehensive Classification Schemes

A. Hemolytic Activity on Blood Agar

Streptococci are primarily classified based on their phenotypic appearance on blood agar plates:

  1. Alpha Hemolysis: Greenish discoloration and partial lysis of erythrocytes (1 to 2 mm wide zone with irregular margins). Examples: Streptococcus pneumoniae and the Streptococcus viridans group.
  2. Beta Hemolysis: A sharply defined, completely clear, and colorless zone of hemolysis (2 to 4 mm wide). Example: Streptococcus pyogenes.
  3. Gamma Hemolysis: No zone of hemolysis is observed. Example: Enterococci.

B. Lancefield Grouping (For beta-Hemolytic Streptococci)

  • Basis: Classified into 20 serological groups (Groups A to V, excluding I and J) based on the immunological specificity of the group-specific C-carbohydrate antigen present in their cell wall.
  • Human Pathogens: Group A (Streptococcus pyogenes) is the primary human pathogen. Group B (Streptococcus agalactiae) is also clinically significant.
  • Antigen Extraction Methods (High-Yield): The C-carbohydrate must be extracted for serological precipitation grouping using one of the following methods:
    • Lancefield’s Method: Hydrochloric acid (acid extraction).
    • Fuller’s Method: Formamide extraction.
    • Maxted’s Method: Enzymatic extraction using Streptomyces albus filtrate.
    • Rantz and Randall’s Method: Autoclaving.

C. Griffith Typing

  • Basis: Group A streptococci are further subdivided into more than 80 distinct serotypes based on the type-specific surface M, T, and R proteins.

3. Streptococcus pyogenes (Group A): Surface Antigens & Virulence Profile

  • Morphology: Cocci measuring 0.5 to 1 m in diameter, arranged in chains. The capsule, when present, is composed of hyaluronic acid (identical to host connective tissue, making it non-immunogenic).
  • Fimbriae: Hair-like projections consisting of M protein covered by lipoteichoic acid, which mediates initial adherence to host fibronectin receptors on epithelial cells.

Key Surface Virulence Factors:

  • M Protein: The principal virulence factor. It is antiphagocytic (inhibits leukocyte phagocytosis), and type-specific antibodies to it are protective. It is alcohol-soluble and destroyed by trypsin.
  • T and R Proteins: Surface proteins with no relation to virulence. T protein is trypsin-resistant and demonstrated by agglutination.
  • Lipoteichoic Acid: Promotes epithelial cell adhesion.

4. Streptococcus pyogenes: Extracellular Toxins & Enzymes

A. Hemolysins

  • Streptolysin O (SLO):
    • Properties: Oxygen-labile, heat-labile, and highly antigenic. It is hemolytically active only in the reduced state and inactivated in the oxidized state.
    • Pathogenesis: Cardiotoxic and lethal. It shares structural similarities with pneumolysin, tetanolysin, and perfringolysin.
    • Diagnostic Import: Stimulates antibody production. An ASO titer >200 units/ml is a key marker of recent streptococcal infection. (Note: ASO remains low in skin-related pyoderma/AGN).
  • Streptolysin S (SLS):
    • Properties: Oxygen-stable, serum-soluble, and non-antigenic. It is responsible for the surface hemolysis observed on aerobic blood agar plates. It is nephrotoxic.

B. Erythrogenic Toxin / Streptococcal Pyrogenic Exotoxin (SPE)

  • Mechanism: Acts as a Superantigen, non-specifically binding to MHC class II and T-cell receptors (TCR V\(\beta\) regions), driving a massive release of cytokines.
  • Genetics: Composed of three antigenic types (SPE A, B, and C). Production of types A and C is bacteriophage-coded (lysogenic conversion), while type B is chromosomal.
  • Clinical Impact: Responsible for the erythematous rash of Scarlet Fever and mediates Streptococcal Toxic Shock Syndrome (TSS).
  • Tests:
    • Dick Test: Intradermal injection of toxin produces erythema in susceptible individuals.
    • Schultz-Charlton Reaction: Injection of specific antitoxin causes local blanching of the scarlet fever rash (diagnostic).

C. Spreading Enzymes

  • Streptokinase (Fibrinolysin): Converts plasminogen to plasmin, lysing fibrin clots. It prevents the formation of a fibrin barrier around lesions, promoting the rapid spread of infection.
    • Therapeutic Application: Clinically used as a thrombolytic agent in coronary thrombosis.
  • Deoxyribonucleases (Streptodornase): Depolymerizes free DNA in purulent secretions, liquefying thick pus. Four types exist (A, B, C, D).
    • Diagnostic Import: Anti-DNase B titers (>300-350 U) are highly useful for the retrospective diagnosis of skin infections (pyoderma) and post-streptococcal acute glomerulonephritis (AGN), where ASO titers are typically low.
  • Hyaluronidase: Spreading factor that degrades the hyaluronic acid matrix of connective tissues. Strains producing large amounts of hyaluronidase (e.g., M types 4 and 22) are typically non-capsulated.

5. Suppurative vs. Non-Suppurative Clinical Syndromes

┌───────────────────────────────┐
│ Streptococcus pyogenes │
└───────────────┬───────────────┘
┌───────────────────────┴───────────────────────┐
▼ ▼
[Suppurative Infections] [Non-Suppurative Sequelae]
• Pharyngitis/Sore Throat (Latent period: 1-3 weeks)
• Erysipelas & Cellulitis
• Impetigo (Honeycomb crusts) ┌───────────┴───────────┐
• Necrotizing Fasciitis (Flesh-eating) ▼ ▼
• Puerperal Sepsis Rheumatic Fever AGN
• Streptococcal TSS (Throat only) (Throat or Skin)

A. Suppurative Infections

  1. Pharyngitis (Sore Throat): The most common bacterial cause, typically associated with lower M types.
  2. Skin and Soft Tissue Infections:
    • Impetigo (Pyoderma): Painless, pustular lesions forming characteristic honeycomb-like crusts in young children. Associated with higher M types and nephritogenic strains.
    • Erysipelas & Cellulitis: Erysipelas involves superficial lymphatics, presenting as bright red, swollen, and indurated skin with a "peau d'orange" texture. The malar face is a classic site in older adults. S. pyogenes is the most common cause of cellulitis.
    • Necrotizing Fasciitis (Flesh-Eating Disease): A rapidly progressive, life-threatening infection of deep subcutaneous tissue. Characterized by severe pain, fever, discoloration, and systemic shock. Surgical debridement is the most crucial therapeutic step.
  3. Puerperal Sepsis: Historically a major cause of maternal mortality.
  4. Streptococcal Toxic Shock Syndrome (TSS): Unlike Staphylococcal TSS, bacteremia is highly common, and it is frequently associated with severe soft-tissue necrosis (necrotizing fasciitis).

B. Non-Suppurative Sequelae (The Autoimmune Post-Infectious Diseases)

These conditions occur 1 to 3 weeks after infection, and no live organisms are detected in the lesions. They result from antigenic cross-reactivity (molecular mimicry) between streptococcal antigens and human tissue proteins:

Streptococcal AntigenMammalian Cross-Reactive TargetClinical Sequelae
Capsular Hyaluronic AcidSynovial FluidReactive Arthritis / Joint pain
Cell Wall M ProteinMyocardiumAcute Rheumatic Fever (ARF)
Cell Wall C-CarbohydrateCardiac ValvesRheumatic Valvular Disease (SABE risk)
Protoplast/Cytoplasmic MembraneVascular Intima / GlomerulusAcute Glomerulonephritis (AGN)
PeptidoglycanSkin AntigensGuttate Psoriasis

Comparative Pathology: Acute Rheumatic Fever (ARF) vs. Acute Glomerulonephritis (AGN)

FeatureAcute Rheumatic Fever (ARF)Acute Glomerulonephritis (AGN)
Preceding Site of InfectionThroat strictly (Pharyngitis)Throat OR Skin (Pyoderma/Impetigo)
Nephritogenic SerotypesAny serotypePyodermal (49, 53-55, 59-61); Pharyngeal (1, 12)
Complement LevelsUnalteredLow / Decreased (marker of active disease)
Repeated AttacksCommonAbsent / Non-recurring (type-specific immunity)
Penicillin ProphylaxisIndicated & Essential (prevents recurrence)Not indicated
Prognosis & CourseProgressive; variable prognosisSpontaneous resolution; good prognosis

6. Group B Streptococcus (Streptococcus agalactiae)

  • Clinical Epidemiology: Normal commensal of the gut and female genital tract. responsible for mastitis in cows.
  • Pathogenesis:
    • Puerperal Sepsis in mothers.
    • Early-Onset Neonatal Disease: Manifests within 1 week of birth (typically first 48 hours). Acquired via vertical transmission during delivery. Classically presents as neonatal pneumonia, respiratory distress, and septicemia.
    • Late-Onset Neonatal Disease: Manifests in infants 1 week to 3 months of birth. Characterized predominantly by neonatal meningitis, classically associated with the capsular type III antigen.
  • Laboratory Identification:
    • Bacitracin resistant and PYR negative (differentiates it from Group A).
    • Hippurate Hydrolysis positive.
    • CAMP Test Positive: Secretes a diffusible phospholipase (CAMP factor) that acts synergistically with the \(\beta\)-lysin of Staphylococcus aureus to produce a highly characteristic arrowhead-shaped zone of complete hemolysis.

7. Group D Streptococci: Enterococci & VRE Dynamics

Group D streptococci are distinguished by their ability to grow in the presence of 40% bile and hydrolyze esculin. They are divided into Enterococci and Non-enterococci.

Enterococci (Enterococcus faecalis, Enterococcus faecium):

  • Growth Tolerances (Extreme Survival):
    • Can grow in 6.5% NaCl, 40% bile, at pH 9.6, and at 45°C.
    • Survives heating at 60°C for 30 minutes.
  • Key Identification Tests: PYR-positive, Esculin-hydrolysis positive, and produce black colonies on tellurite blood agar.
  • Clinical Syndromes: Normal gastrointestinal flora; breach of mucosa leads to spillage causing peritonitis, UTIs, and subacute endocarditis. They exhibit intrinsic resistance to penicillins and low-level aminoglycosides (synergized clinically by combining both).
  • Vancomycin-Resistant Enterococci (VRE):
    • Mechanism: Mediated by Van genes (e.g., vanA). It alters the target cell wall precursor from D-Alanine-D-Alanine to D-Alanine-D-Serine or D-Alanine-D-Lactate, which has a significantly lower binding affinity for vancomycin.

8. Streptococcus pneumoniae (Pneumococcus) vs. Viridans Streptococci

Both produce alpha  hemolysis (greenish discoloration) on blood agar, making their laboratory differentiation a critical exam focus:

PropertyStreptococcus pneumoniae (Pneumococcus)Streptococcus viridans (Oral Streptococci)
Morphology & ArrangementLanceolate (flame-shaped) GPC in pairsOval or round GPC in chains
CapsulePresent (detected by Quellung reaction)Absent
Colony Morphology (48h)Draughtsman or carrom-coin shape (flat with raised margins due to central autolysis by amidase)Convex, small pinpoint colonies
Growth in Liquid MediaUniform turbidityGranular turbidity with powdery deposits
Bile SolubilitySoluble (lysed in bile; clearing of turbidity)Insoluble
Inulin FermentationFermenterNon-fermenter
Optochin SensitivitySensitive (zone of inhibition \(\ge 14\) mm around 5 \(\mu\)g disc)Resistant
Animal PathogenicityIntraperitoneal inoculation in mice causes fatal septicemiaNon-pathogenic

A. Pneumococcal Virulence & Pathogenesis:

  • Capsule: The primary virulence factor, inhibiting phagocytosis. There are over 90 capsular types.
  • Enzymes: Secretes IgA2 protease (destroys mucosal IgA), neuraminidase, and Pneumolysin (an oxygen-labile cytolytic toxin structurally similar to Streptolysin O).
  • Clinical Presentation:
    • Lobar Pneumonia: The most common cause of pyogenic lobar pneumonia. Classic rusty sputum. Type 3 is the most virulent capsular type.
    • Meningitis: A highly virulent cause of adult bacterial meningitis, particularly in splenectomized patients (spleen is critical for filtering capsulated organisms).
    • Otitis Media: The most common pneumococcal syndrome in pediatric populations.
  • Vaccines:
    • 23-Valent Polysaccharide Vaccine: Covers 90% of strains; T-independent antigen, hence not useful for children under 2 years.
    • Conjugated Vaccine (7-Valent or expanded): Polysaccharides conjugated to a protein carrier (diphtheria toxoid); highly immunogenic in children under 2 years.

B. Viridans Group Streptococci (S. mutans, S. sanguis, S. mitis):

  • Dental Caries: Streptococcus mutans ferments sucrose to produce extracellular glucans, forming dental plaque.
  • Subacute Bacterial Endocarditis (SABE): Following dental procedures or tooth extraction, transient bacteremia allows Streptococcus sanguis or other viridans strains to lodge onto previously damaged or rheumatic heart valves. Penicillin prophylaxis is clinically implemented prior to dental extractions in susceptible patients.

9. Laboratory Identification Summary Table

OrganismHemolysisGram StainKey Diagnostic Features
S. pyogenes (Group A)Beta GPC in chainsBacitracin-sensitive, PYR-positive, ASO >200.
S. agalactiae (Group B)Beta GPC in chainsBacitracin-resistant, CAMP-positive, Hippurate-positive.
S. pneumoniaeAlpha Lanceolate diplococciOptochin-sensitive, Bile-soluble, Inulin-fermenter, Capsulated.
S. viridansAlpha GPC in chainsOptochin-resistant, Bile-insoluble, Inulin non-fermenter.
Enterococci (Group D)Gamma GPC in pairs/short chainsGrows in 6.5% NaCl, black colonies on tellurite.

Competitive Exam Booster Bullet Points

  • Transport medium of choice for S. pyogenes: Pike’s medium.
  • Selective media for S. pyogenes: Crystal violet blood agar or PNF (Polymyxin-Neomycin-Fusidic acid) medium.
  • Oxygen-labile, strongly antigenic hemolysin: Streptolysin O.
  • Oxygen-stable, non-antigenic surface hemolysin: Streptolysin S.
  • Toxin dependent on lysogenic conversion: SPE A and SPE C (bacteriophage-coded).
  • ASO titer significance in post-streptococcal sequelae: Elevated in ARF; typically low or negative in skin pyoderma and AGN (use Anti-DNase B instead).
  • Spleen's major role in Streptococcal infection: Clear opsonized capsulated S. pneumoniae via phagocytosis; splenectomy increases fatal pneumococcemia risk.


Saturday, 22 August 2026

Staphylococcus

1. Introduction & General Properties

  • The Family: Belongs to the family Micrococcaceae, which is distinguished from Streptococcaceae by being catalase-positive.
  • History: The genus was named by Sir Alexander Ogston in 1881.
  • Morphology: They are Gram-positive, spherical cocci (0.8 to 0.9 µm in diameter) arranged in grape-like clusters. Cluster formation occurs because cell division takes place in three planes, with daughter cells tending to remain close together. They are non-motile, non-sporing, and rarely capsulated.
  • Carriage: Asymptomatic carriage of Staphylococcus aureus is found in up to 40% of healthy individuals. The anterior nares is the most common site of colonization, followed by the skin, axilla, groins, and perineum.

2. Cultural Characteristics & Pigmentation

  • Growth Conditions: Aerobic and facultative anaerobic; grows readily on simple media at an optimum temperature of 37°C and pH 7.4.
  • Nutrient Agar: Produces circular, smooth, shiny, opaque colonies (2 to 4 mm, pinhead size). Pathogenic strains produce a characteristic golden-yellow pigment due to beta-carotene.
    • High-Yield Exam Point: Pigment production occurs optimally at room temperature (20° to 25°C) and strictly under aerobic conditions on solid media in the presence of light. Incorporation of 1% glycerol monoacetate or milk agar enhances pigmentation.
  • Blood Agar: Shows pinhead-sized colonies with a narrow, clear zone of beta-hemolysis.
  • MacConkey Agar: Produces minute, pink lactose-fermenting colonies.
  • Selective Media:
    • Mannitol Salt Agar (MSA): Contains 7.5% NaCl, which inhibits most other bacteria. S. aureus ferments mannitol, turning the phenol red indicator yellow.
    • Salt milk agar (8% to 10% NaCl) and Ludlam's lithium chloride/tellurite medium.
  • Micrococcus vs. Staphylococcus (Hugh & Leifson’s O-F Test): Staphylococcus ferments glucose fermentatively, while Micrococcus utilizes it oxidatively.

3. Antigenic Structure & Surface Virulence Factors

  • Peptidoglycan: A thick, rigid cell wall component that elicits IL-1 production by monocytes and acts as a chemoattractant for neutrophils.
  • Teichoic Acid: Polymers of ribitol/glycerol phosphate linked to peptidoglycan. It facilitates mucosal attachment and protects the cocci from complement-mediated opsonization.
  • Protein A: A major cell wall component of S. aureus (classically the Cowan 1 strain).
    • High-Yield Mechanism: It binds strongly to the Fc portion of IgG molecules, leaving the Fab portion free to combine with specific antigens. This is the biological basis of the co-agglutination reaction used in diagnostic kits. It also acts as a B-cell mitogen and is antiphagocytic.
  • Clumping Factor (Bound Coagulase) vs. Free Coagulase:
PropertyClumping Factor (Bound Coagulase)Free Coagulase (Coagulase Factor)
LocationBound to the bacterial cell wall surface.Secreted outside the bacterial cell.
Heat StabilityHeat-stable.Heat-labile.
CRF RequirementDoes not require Coagulase Reacting Factor (CRF).Requires CRF in host plasma to convert fibrinogen to fibrin.
Diagnostic TestSlide coagulase test (demonstrates clumping).Tube coagulase test (demonstrates clot formation).

4. Extracellular Toxins & Enzymes

  • Hemolysins: Produces four distinct types (alpha, beta, gamma, delta).
    • Alpha-hemolysin: Rapidly lyses rabbit and sheep erythrocytes; it is cardiotoxic, leukocidal, and dermo-necrotoxic.
    • Beta-hemolysin: A sphingomyelinase that lyses sheep RBCs (not human/rabbit) and exhibits the classic "hot-cold" phenomenon (hemolysis is enhanced by incubation at 37°C followed by chilling at 4°C).
  • Leucocidins (Panton-Valentine Toxin / PVL): A bicomponent toxin (F and S components) that damages polymorphonuclear leukocytes (PMNs) and macrophages. It is strongly associated with Community-acquired MRSA (CA-MRSA) skin and soft tissue infections.
  • Synergohymenotropic Toxins: Bicomponent membrane-active toxins composed of gamma-hemolysin and PVL.
  • Epidermolytic (Exfoliative) Toxin: Exists as two proteins (Type A is heat-stable/chromosomal; Type B is heat-labile/plasmid-mediated).
    • Clinical Impact: Causes Scalded Skin Syndrome (SSSS) by separating the epidermal layers (positive Nikolsky’s sign). Severe forms include Ritter’s disease in newborns and Toxic Epidermal Necrolysis (TEN) in adults; milder forms include pemphigus neonatorum and bullous impetigo.
  • Enterotoxins: Produced by nearly 50% of clinical isolates.
    • Pathogenesis: Causes classical Staphylococcal Food Poisoning (most commonly Type A). It is highly heat-stable (not destroyed by boiling) and trypsin-resistant.
    • Clinical Presentation: Ingestion of preformed toxin in contaminated dairy or meat products leads to rapid onset of nausea, projectile vomiting, and diarrhea within 1 to 6 hours. The emetic effect is mediated through vagus nerve and vomiting center stimulation.
  • Toxic Shock Syndrome Toxin-1 (TSST-1): Formerly known as enterotoxin F or pyogenic exotoxin C.
    • Pathogenesis: Acts as a Superantigen, non-specifically binding MHC class II and Vβ regions of T-cell receptors, triggering a massive cytokine storm (IL-1, TNF).
    • Clinical Presentation: Classically associated with the use of vaginal tampons in menstruating women. Presents with high fever, scarlatiniform rash, hypotension, and multi-organ failure.
    • Treatment: Clindamycin is added to therapy because it actively halts toxin synthesis.

5. Clinical Syndromes

  • Cutaneous Infections: Folliculitis, furuncles (boils), carbuncles, impetigo, wound infections, and mastitis.
  • Tropical Pyomyositis: S. aureus is the overall most common cause of deep skeletal muscle abscesses in the tropics. (Note: S. pyogenes causes acute bacterial myositis).
  • Deep-Seated Infections:
    • Osteomyelitis & Septic Arthritis: The most common bacterial cause (frequently affecting the knee joint).
    • Endocarditis: A rapid, highly destructive acute infective endocarditis. In intravenous drug abusers, it classically affects the right-sided tricuspid valve.
    • Pneumonia: Rare, but classically occurs as a severe secondary bacterial cavitating pneumonia following influenza, frequently demonstrating characteristic pneumatoceles on chest X-rays.

6. Diagnostic & Biochemical Confirmation

  1. Catalase Test: Positive (GPC in clusters).
  2. Coagulase Test: Positive.
  3. Mannitol Fermentation: Positive.
  4. DNAse Test: Positive.
  5. Phosphatase Test: Positive. Inoculated on phenolphthalein diphosphate agar; when exposed to ammonia vapor, colonies turn bright pink.

7. Drug Resistance Patterns (Crucial for PG Exams!)

A. Penicillin Resistance (90% of strains)

  • Mechanism: Production of plasmid-controlled beta-lactamase (penicillinase) which inactivates penicillin.
  • Transfer: Transferred between strains primarily by transduction (bacteriophage-mediated).

B. MRSA (Methicillin-Resistant S. aureus)

  • Mechanism: Mediated by the chromosomal mecA gene, located on a 30 to 50 Kb transposon-like DNA segment. It encodes a novel transpeptidase, PBP2a (or PBP2'), which has a remarkably low binding affinity for beta-lactam antibiotics, allowing cell wall cross-linking to continue even in their presence.
  • Diagnostic Surrogate: Cefoxitin disc diffusion is utilized as the preferred surrogate screening marker. Alternatively, PCR for the mecA gene provides definitive detection.
  • Treatment: Vancomycin is the drug of choice. Ceftobiprole is a unique fifth-generation cephalosporin with anti-MRSA activity.

C. VISA & VRSA (Vancomycin-Resistant Strains)

  • VISA (Intermediate): Due to cell wall remodeling leading to an increased thickness of the peptidoglycan cell wall, trapping vancomycin molecules.
  • VRSA (Resistant): Mediated by the vanA or vanB genes acquired via horizontal gene transfer from Vancomycin-Resistant Enterococci (VRE).

8. Coagulase-Negative Staphylococci (CoNS)

A. Staphylococcus epidermidis

  • Epidemiology: Represents 60% to 70% of CoNS isolates and is part of the normal skin flora.
  • Pathogenesis: Produces an extracellular polysaccharide matrix (slime/biofilm). This allows the organism to adhere tenaciously to prosthetic materials.
  • Clinical Import: The leading cause of infections associated with intravenous central lines (CVP), prosthetic heart valves, cardiac shunts, and artificial joints.
  • Novobiocin Status: Characteristically sensitive to Novobiocin.

B. Staphylococcus saprophyticus

  • Clinical Import: A major cause of acute urinary tract infections (UTIs) in young, sexually active females.
  • Novobiocin Status: Highly resistant to Novobiocin, which rapidly distinguishes it from S. epidermidis.

9. Laboratory Diagnosis: Identifying the Culprit

The clinical laboratory utilizes a systematic approach to identify staphylococcal species:

  1. Specimen Collection: Samples include pus aspirates, blood for culture, or swabs from deep wounds.
  2. Microscopy: Gram staining to identify Gram-positive clusters among polymorphonuclear leucocytes.
  3. Biochemical Identification: The Coagulase test is the definitive tool to distinguish the highly pathogenic S. aureus (coagulase-positive) from the less virulent CoNS (e.g., S. epidermidis).
  4. Phenotypic MRSA Detection: The Cefoxitin disc diffusion test is the standard laboratory method for detecting MRSA, as Cefoxitin is a potent inducer of the mecA gene.

💡 Post-Turn Examination Booster

  • Co-agglutination ligand: Protein A.
  • Menstrual TSS toxin: TSST-1.
  • Non-menstrual TSS toxin: Enterotoxins B & C.
  • Surrogate marker for MRSA: Cefoxitin.
  • CA-MRSA associated toxin: Panton-Valentine Leukocidin (PVL).
  • Hot-cold phenomenon: Beta-hemolysin.
  • Bacterial typing of S. aureus: Phage typing (pattern method).


Streptococcus

  1. Introduction & General Properties Taxonomy: Belongs to the family Streptococcaceae , distinguished from Micrococcaceae (Staphyl...